1-4 of 4
Stephen P Kahanic, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longer Term Follow up of the  Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT)

Brian GM Durie, MD, Antje Hoering, PhD, Rachael Sexton, PhD, Muneer H. Abidi, MD, Joshua Epstein, DSc, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Stephen P. Kahanic, MD, Mohan C. Thakuri, MD, Frederic J. Reu, MD, Christopher M. Reynolds, MD, Robert Z. Orlowski, MD PhD, Bart Barlogie, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1992.
https://doi.org/10.1182/blood-2018-99-117003
Published: 2018
Journal Articles

Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT): Results of the Randomized Phase III Trial SWOG S0777

Brian Durie, MD, Antje Hoering, PhD, S. Vincent Rajkumar, MD, Muneer H. Abidi, MD, Joshua Epstein, DSc, Stephen P. Kahanic, MD, Mohan C. Thakuri, MD, Frederic J Reu, Christopher M. Reynolds, MD, Rachael Sexton, MS, Robert Z. Orlowski, PhD, MD, Bart Barlogie, MD PhD, Angela Dispenzieri, MD
Journal: Blood
Blood (2015) 126 (23): 25.
https://doi.org/10.1182/blood.V126.23.25.25
Published: 2015
Journal Articles

Results of a Phase II Study with Bendamustine and Ofatumumab in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma

Nathan H. Fowler, MD, Stephen P. Kahanic, MD, Andres Forero, MD, Mihaela C. Munteanu, MS, Glen L. Davis, MS, Peter Brown, DPhil, Eric Van Den Neste, MD, Fritz C. Offner, MD, PhD, Dominique Bron, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2011) 118 (21): 778.
https://doi.org/10.1182/blood.V118.21.778.778
Published: 2011
Journal Articles

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

David P Steensma, MD, Shaker R. Dakhil, MD, Robert Dalton, MD, Stephen P Kahanic, MD, John W Kugler, MD, Philip J Stella, MD, Kendrith M Rowland, Jr., MD, Paul J Novotny, MS, Jeff A Sloan, PhD, Charles L Loprinzi, MD
Journal: Blood
Blood (2009) 114 (22): 630.
https://doi.org/10.1182/blood.V114.22.630.630
Published: 2009